England is 'one of the worst places to get cancer': Patients can't get NHS access to key medicines available in other countries, drugs firm chief says
- Patients are being denied access to key medicines available in other countries,
- Critics have blamed the methods used by the NHS rationing watchdog NICE
- They say it is leading to patients needlessly suffering early deaths
England is one of the worst places in Europe to get cancer, the boss of a major drugs company has warned.
Cancer patients are being denied NHS access to key medicines that are available in other countries, Ben Hickey said.
The UK general manager of Bristol-Myers Squibb blamed archaic and inflexible methods used by rationing watchdog NICE. And he claimed patients are needlessly suffering early deaths as a result.
England has survival rates 10 per cent lower than a group of our European neighbours
Mr Hickey warned that the gulf in cancer survival between England and other European countries is set to grow thanks to new rationing rules. ‘Unfortunately it really is not a good place to be diagnosed with what is a devastating illness,’ he told the Daily Mail.
‘We have seen that from the adoption of innovative therapies, we have seen it in survival rates 10 per cent lower than a group of our European neighbours, we have seen it in the five-year survival in lung cancer being almost half what it is in Austria.’
He said the situation is likely to get worse because the NHS this month introduced the ability to delay the introduction by up to three years of any drug which would cost the health system more than £20million a year. Survival rates for some cancers in Britain lag up to ten years behind those in the best Western European countries.
This is usually put down to late diagnosis, but a 2015 report by health researchers the IMS Institute showed the NHS in England spends less on new cancer treatments per patient than Scotland, Sweden, Canada, Australia, France, Germany, Italy, Spain and the US.
Bristol Myers-Squibb has been in negotiations with NICE about its breakthrough lung cancer medicine, nivolumab. It is one of a new wave of immunotherapy treatments which teach the body’s immune system to attack tumours. In trials it was roughly 16 times more effective than chemotherapy for long-term treatment of advanced lung cancer.
Cancer survival rates in the UK are more than ten years behind other European countries
While 40,000 patients in other European countries including Scotland have been given the drug, NICE argues its £68,000 a year cost is too high, even with the confidential discount offered by the company.
Mr Hickey insisted nivolumab is cost effective and said he was hopeful NICE would change its mind. It is due to make a final decision on nivolumab for lung cancer in the coming weeks. He said the reason survival rates in England lag behind other nations is because NHS health officials view medicines as an expensive burden.
He added: ‘We are still using an archaic model which is based on chemotherapy to evaluate innovative medicines such as immunotherapy. The flexibility doesn’t exist.’
Sir Andrew Dillon, chief executive of NICE, defended its methods and said companies have to price their drugs responsibly. He said it had recommended nivolumab for skin and kidney cancer, but there were uncertainties around its benefits in lung cancer.
NHS England said NHS cancer survival rates are at a record high.
Most watched News videos
- Terrifying moment driver overtakes van and narrowly avoids crash
- Sally Nugent hilariously finds out 'hedgehog' is a hat bobble
- Starmer and Rayner embrace as they launch election campaign
- Three men seen running out of Beckenham station after knife attack
- 'Satan took over me': Hamas terrorist confesses of raping woman
- Heartless criminals steal van terminally ill boy uses
- Camilla hands out gifts at Royal Maundy ceremony on behalf of King
- Tourist is filmed napping in his tent on the beach with a crocodile
- Hilarious moment King's Guard shout 'make way' at pigeons in London
- Police carry slingshots to defend themselves against crazed monkeys
- Russian plane spiralling out of control crashes in sea in Crimea
- Queen Camilla greets children after traditional Maundy service